Centennial Bank’s AstraZeneca AZN Stock Holding History

Centennial Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$93K	Hold	480	–	–	0.03%	179
2025 Q4	$88.3K	Hold	480	–	–	0.04%	183
2025 Q3	$73.7K	Hold	480	–	–	0.03%	189
2025 Q2	$67.1K	Hold	480	–	–	0.03%	194
2025 Q1	$70.6K	Hold	480	–	–	0.03%	180
2024 Q4	$62.9K	Hold	480	–	–	0.03%	185
2024 Q3	$74.8K	Hold	480	–	–	0.03%	176
2024 Q2	$74.9K	Hold	480	–	–	0.04%	170
2024 Q1	$65K	Hold	480	–	–	0.03%	172
2023 Q4	$64.7K	Hold	480	–	–	0.04%	173
2023 Q3	$65K	Hold	480	–	–	0.04%	174
2023 Q2	$68.7K	Hold	480	–	–	0.05%	174
2023 Q1	$66.6K	Hold	480	–	–	0.04%	180
2022 Q4	$65.1K	Buy	+480	New	+$60.2K	0.04%	191

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Centennial Bank's AZN Position: Q1 2026 in Review

Centennial Bank held its AstraZeneca (AZN) position steady in Q1 2026 at 480 shares worth $93K. The position accounts for 0.03% of the portfolio, ranked #179.

Centennial Bank first reported a position in AZN in Q4 2022 and has held it in 14 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Centennial Bank held 480 shares of AstraZeneca worth $93K as of Q1 2026.
Centennial Bank left its AstraZeneca share count unchanged in Q1 2026.
AstraZeneca made up 0.03% of Centennial Bank's portfolio in Q1 2026, its #179 holding.
Centennial Bank first reported a position in AstraZeneca in Q4 2022 and has held it in 14 quarters since.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Centennial Bank's 13F filing for Q1 2026, filed 6 May 2026.